The Psychological, Social, and Economic Impacts of COVID-19

NCT ID: NCT04369690

Last Updated: 2020-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-03

Study Completion Date

2021-04-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A dynamic analytical tool is being implemented to monitor the health, psychosocial and economic impacts of the COVID-19 pandemic as the crisis unfolds. A longitudinal survey is distributed via a network of hospitals, provincial/national organizations and web platforms. The survey information can be linked to provincial health administrative data and metrics derived from social media activity based on artificial intelligence methods. Targeted questions are included for critical populations such as healthcare workers and people with chronic illnesses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The current situation unfolding with regards to the COVID-19 virus is changing core aspects of people's lives in a unique manner. This study aims to examine the psychological, social, and financial impacts of the COVID-19 pandemic at various stages of the outbreak.

Individuals 12 years and older are recruited from three main groups: general population, people with chronic illnesses and healthcare professionals.

An online survey is distributed via multiple hospitals, provincial/national organizations, and web-based platforms at various phases of the outbreak. The survey includes validated questionnaires and custom-made questions to asses the current situation. It notably addresses the following themes: demographics, COVID-19 symptoms and diagnoses, social distancing practices and social interactions, living situation, financial situation, family and work-related challenges, access to healthcare, as well as sleep, physical and mental health.

The survey is available in English and French. It is built on a decisional tree structure with customized subsets of questions based on previous answers.The survey contains an adolescent version and an adult version, and also includes targeted questions for individuals with a current diagnosis of a mental/medical illness. Consent is also sought to link data from parent-child dyads to enable finer analyses of family dynamics. Healthcare staff are invited to answer questions about work-related difficulties, usefulness of virtual tools for clinical practice, as well as moral distress and moral resilience in the context of clinical practice. Healthcare staff who are short on time can chose fill out an abbreviated version. Participants have the option of enabling linkage to linked to provincial health administrative data, and to provide their twitter and facebook handle for social media and mood monitoring through artificial intelligence algorithms. Participants have the option of being followed longitudinally during and after the outbreak.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Chronic Disease Psychiatric Disorder Cardiovascular Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

COVID-19 pandemic psychology social interactions financial impacts mental health stress anxiety depression healthcare professional's health familly sleep occupational life survey social media access to care social distancing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All individuals who are at least 12 years of age

Exclusion Criteria

* None
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

OTHER

Sponsor Role collaborator

Sunnybrook Health Sciences Centre

OTHER

Sponsor Role collaborator

Southlake Regional Health Centre

OTHER

Sponsor Role collaborator

The Ottawa Hospital Research Institute

UNKNOWN

Sponsor Role collaborator

Centre for Addiction and Mental Health

OTHER

Sponsor Role collaborator

Cheo Research Institute

OTHER

Sponsor Role collaborator

Ottawa Heart Institute Research Corporation

OTHER

Sponsor Role collaborator

McGill University

OTHER

Sponsor Role collaborator

Johns Hopkins University

OTHER

Sponsor Role collaborator

Université de Montréal

OTHER

Sponsor Role collaborator

The Royal's Institute of Mental Health Research

OTHER

Sponsor Role collaborator

University of Ottawa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rébecca Robillard

Dr. Rebecca Robillard

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rébecca Robillard, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Ottawa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southlake Regional Health Centre

Newmarket, Ontario, Canada

Site Status NOT_YET_RECRUITING

CHEO Research Institute

Ottawa, Ontario, Canada

Site Status RECRUITING

The Ottawa Hospital Research Institute

Ottawa, Ontario, Canada

Site Status RECRUITING

The Centre for Addiction and Mental Health

Ottawa, Ontario, Canada

Site Status NOT_YET_RECRUITING

The University of Ottawa Heart Institute

Ottawa, Ontario, Canada

Site Status RECRUITING

The Royal's Institute of Mental Health Research

Ottawa, Ontario, Canada

Site Status RECRUITING

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Site Status NOT_YET_RECRUITING

Hôpital en santé mentale Rivière-des-Prairies (CIUSSS du Nord-de-l'Île-de-Montréal)

Montreal, Quebec, Canada

Site Status NOT_YET_RECRUITING

McGill University

Montreal, Quebec, Canada

Site Status NOT_YET_RECRUITING

University of Montréal

Montreal, Quebec, Canada

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rébecca Robillard, PhD

Role: CONTACT

Phone: 613-722-6521

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Janet Jeffrey, RN, PhD

Role: primary

Addo Boafo, MD

Role: primary

Tetyana Kendzerska, MD PhD

Role: primary

Lena Quilty, PhD, CPsych

Role: primary

Jodi Edwards, PhD

Role: primary

Rébecca Robillard

Role: primary

Richard Swartz, MD, PhD

Role: primary

Kaitlyn Lopes

Role: backup

Roger Godbout, PhD

Role: primary

Marie-Hélène Pennestri, PhD

Role: primary

Denis Lafortune, PhD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Robillard R, Saad M, Edwards J, Solomonova E, Pennestri MH, Daros A, Veissiere SPL, Quilty L, Dion K, Nixon A, Phillips J, Bhatla R, Spilg E, Godbout R, Yazji B, Rushton C, Gifford WA, Gautam M, Boafo A, Swartz R, Kendzerska T. Social, financial and psychological stress during an emerging pandemic: observations from a population survey in the acute phase of COVID-19. BMJ Open. 2020 Dec 12;10(12):e043805. doi: 10.1136/bmjopen-2020-043805.

Reference Type DERIVED
PMID: 33310814 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2131

Identifier Type: -

Identifier Source: org_study_id